<VariationArchive VariationID="1208140" VariationName="NM_000082.4(ERCC8):c.611_616del (p.Thr204_Ala205del)" VariationType="Deletion" Accession="VCV001208140" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-19" DateCreated="2021-08-21" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1197391" VariationID="1208140">
      <GeneList>
        <Gene Symbol="ERCC8" FullName="ERCC excision repair 8, CSA ubiquitin ligase complex subunit" GeneID="1161" HGNC_ID="HGNC:3439" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="60866454" stop="60945070" display_start="60866454" display_stop="60945070" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="60169658" stop="60240904" display_start="60169658" display_stop="60240904" Strand="-" />
          </Location>
          <OMIM>609412</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000082.4(ERCC8):c.611_616del (p.Thr204_Ala205del)</Name>
      <CanonicalSPDI>NC_000005.10:60902442:TTGCTGTTGC:TTGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="60902443" stop="60902448" display_start="60902443" display_stop="60902448" variantLength="6" positionVCF="60902442" referenceAlleleVCF="CTTGCTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="60198270" stop="60198275" display_start="60198270" display_stop="60198275" variantLength="6" positionVCF="60198269" referenceAlleleVCF="CTTGCTG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_466t1" sequenceAccession="LRG_466t1">
            <Expression>LRG_466t1:c.611_616del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.60902447_60902452del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.60902447_60902452del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.60198274_60198279del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.60198274_60198279del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009289.1" sequenceAccession="NG_009289" sequenceVersion="1" change="g.47631_47636del">
            <Expression>NG_009289.1:g.47631_47636del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000082.4" sequenceAccession="NM_000082" sequenceVersion="4" change="c.611_616del" MANESelect="true">
            <Expression>NM_000082.4:c.611_616del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000073.1" sequenceAccession="NP_000073" sequenceVersion="1" change="p.Thr204_Ala205del">
            <Expression>NP_000073.1:p.Thr204_Ala205del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007233.3" sequenceAccession="NM_001007233" sequenceVersion="3" change="c.437_442del">
            <Expression>NM_001007233.3:c.437_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007234.1" sequenceAccession="NP_001007234" sequenceVersion="1" change="p.Thr146_Ala147del">
            <Expression>NP_001007234.1:p.Thr146_Ala147del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001290285.2" sequenceAccession="NM_001290285" sequenceVersion="2" change="c.152_157del">
            <Expression>NM_001290285.2:c.152_157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001277214.1" sequenceAccession="NP_001277214" sequenceVersion="1" change="p.Thr51_Ala52del">
            <Expression>NP_001277214.1:p.Thr51_Ala52del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_466" sequenceAccession="LRG_466">
            <Expression>LRG_466:g.47631_47636del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000082.3" sequenceAccession="NM_000082" sequenceVersion="3" change="c.611_616del6">
            <Expression>NM_000082.3:c.611_616del6</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000082.4" sequenceAccession="NM_000082" sequenceVersion="4" change="c.611_616delCAGCAA" MANESelect="true">
            <Expression>NM_000082.4:c.611_616delCAGCAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2112491212" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000082.4(ERCC8):c.611_616del (p.Thr204_Ala205del) AND not provided" Accession="RCV001576345" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000082.4(ERCC8):c.611_616del (p.Thr204_Ala205del) AND Cockayne syndrome" Accession="RCV003492265" Version="1">
        <ClassifiedConditionList TraitSetID="13315">
          <ClassifiedCondition DB="MedGen" ID="C0009207">Cockayne syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000082.4(ERCC8):c.611_616del (p.Thr204_Ala205del) AND ERCC8-related disorder" Accession="RCV003399385" Version="4">
        <ClassifiedConditionList TraitSetID="89386">
          <ClassifiedCondition>ERCC8-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-23" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-04" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-08-21" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14661080</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16949367</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29531219</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32048102</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-02-24">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89386" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70030" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ERCC8-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ERCC8-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="13315" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6530" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome</ElementValue>
                <XRef ID="MONDO:0016006" DB="MONDO" />
                <XRef ID="21086008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dwarfism-retinal atrophy-deafness syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progeria-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progeroid nanism</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6122" />
                <XRef ID="6122" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="C0009207" DB="MedGen" />
              <XRef ID="MONDO:0016006" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3536543" SubmissionDate="2022-02-23" DateLastUpdated="2023-03-04" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="GDXSV:221696" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001803510" DateUpdated="2023-03-04" DateCreated="2021-08-21" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 2 amino acids in a non-repeat region predicted to critically alter the protein; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC8" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4351240</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000082.3:c.611_616del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_26_20210819132751</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_89_20220223054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7691921" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="27227979|ERCC8-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004104160" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The ERCC8 c.611_616del6 variant is predicted to result in an in-frame deletion (p.Thr204_Ala205del). Variants disrupting the Thr204 or Ala205 amino acid residues have been reported in the compound heterozygous state in individuals with Cockayne syndrome (Cao et al. 2004. PubMed ID: 14661080; Bertola et al. 2006. PubMed ID: 16865293; Cho et al. 2020. PubMed ID: 32048102). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000082.3:c.611_616del6</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ERCC8-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7917499" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_000082.4:c.611_616delCAGCAA|MedGen:C0009207" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004241577" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: ERCC8 c.611_616delCAGCAA (p.Thr204_Ala205del) results in an in-frame deletion that is predicted to remove two amino acids from the encoded protein. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 250866 control chromosomes. To our knowledge, no occurrence of c.611_616delCAGCAA in individuals affected with Cockayne Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. However, Ala205Pro has been classified as pathogenic in ClinVar, suggesting a functional importance of this residue. Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000082.4:c.611_616delCAGCAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009207" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14175850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5624923" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="11957033|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002931208" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14661080</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16949367</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29531219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32048102</ID>
          </Citation>
          <Comment>This variant, c.611_616del, results in the deletion of 2 amino acid(s) of the ERCC8 protein (p.Thr204_Ala205del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ERCC8-related conditions. ClinVar contains an entry for this variant (Variation ID: 1208140). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the ERCC8 protein in which other variant(s) (p.Ala205Pro) have been determined to be pathogenic (PMID: 14661080, 16949367, 29531219, 32048102). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.60198270_60198275del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7917499" TraitType="Disease" MappingType="XRef" MappingValue="C0009207" MappingRef="MedGen">
        <MedGen CUI="C0009207" Name="Cockayne syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5624923" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3536543" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7691921" TraitType="Disease" MappingType="Name" MappingValue="ERCC8-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ERCC8-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

